(LEGN) |
| 0 (0%) 02-26 05:09 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 25.74 |
| Resistance 1: | 22.04 |
| Pivot price: | 18.11 |
| Support 1: | 18.46 |
| Support 2: | 16.24 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | -1.280 |
| Book Value | 5.470 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.718 |
| Profit Margin (%) | -26.37 |
| Operating Margin (%) | -15.96 |
| Return on Assets (ttm) | -6.9 |
| Return on Equity (ttm) | -22.5 |
Company news
Wed, 25 Feb 2026
(LEGN) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Tue, 24 Feb 2026
Legend Biotech (LEGN) stock slips in premarket after 9% surge as Gilead-Arcellx deal spotlights Carvykti rivals - TechStock²
Tue, 24 Feb 2026
H.C. Wainwright Maintains Legend Biotech(LEGN.US) With Buy Rating, Maintains Target Price $50 - 富途牛牛
Mon, 23 Feb 2026
Legend Biotech (LEGN) Valuation Check After Barclays Update And 2026 Profitability Targets - Yahoo Finance
Mon, 23 Feb 2026
Legend Biotech (LEGN) Shares Surge Over 16% - GuruFocus
Mon, 23 Feb 2026
Legend Biotech Corporation (LEGN): Analyst Consensus Highlights 248% Potential Upside - DirectorsTalk Interviews
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
